0.3263
price up icon12.95%   0.0374
after-market After Hours: .30 -0.0263 -8.06%
loading

Virpax Pharmaceuticals Inc Stock (VRPX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
29.50%
3.3025
4.6841 6.1151 3.2395 1.6511
Operating Income/Loss
29.50%
-3.3025
-4.6841 -6.1151 -3.2395 -1.6511
Nonoperating Income/Loss
0.082
- - - -
Income/Loss From Continuing Operations Before Tax
29.40%
-3.2204
-4.5617 -5.9945 -3.1128 -1.5205
Income/Loss From Continuing Operations After Tax
29.40%
-3.2204
-4.5617 -5.9945 -3.1128 -1.5205
Net Income/Loss
29.40%
-3.2204
-4.5617 -5.9945 -3.1128 -1.5205
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
111.11%
1.1712
-10.54 11.71 11.71 11.71
Diluted Average Shares
111.11%
1.1712
-10.54 11.71 11.71 11.71
Basic Earnings Per Share
77.20%
-2.75
-12.06 -0.51 -0.27 -0.13
Diluted Earnings Per Share
77.20%
-2.75
-12.06 -0.51 -0.27 -0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$79.31
price up icon 0.81%
$21.37
price down icon 2.06%
$370.58
price up icon 0.04%
$4.94
price up icon 7.39%
biotechnology ONC
$230.86
price up icon 2.38%
$119.83
price down icon 2.40%
Cap:     |  Volume (24h):